75 related articles for article (PubMed ID: 1477804)
21. MAPREC assay for quantitation of mutants in a recombinant flavivirus vaccine strain using near-infrared fluorescent dyes.
Bidzhieva B; Laassri M; Chumakov K
J Virol Methods; 2011 Jul; 175(1):14-9. PubMed ID: 21514323
[TBL] [Abstract][Full Text] [Related]
22. A novel genetic marker to differentiate feline herpesvirus type 1 field isolates.
Hamano M; Maeda K; Kai K; Mochizuki M; Tohya Y; Akashi H
Vet Microbiol; 2005 Apr; 106(3-4):195-200. PubMed ID: 15778025
[TBL] [Abstract][Full Text] [Related]
23. A recombinant replication-defective human adenovirus type 3: a vaccine candidate.
Li H; Zhou R; Chen J; Tian X; Zhang Q; Zeng Q; Gong S
Vaccine; 2009 Jan; 27(1):116-22. PubMed ID: 18977265
[TBL] [Abstract][Full Text] [Related]
24. Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus.
Bastien N; Trudel M; Simard C
Virology; 1997 Jul; 234(1):118-22. PubMed ID: 9234952
[TBL] [Abstract][Full Text] [Related]
25. Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine.
Henderson H; Jackson F; Bean K; Panasuk B; Niezgoda M; Slate D; Li J; Dietzschold B; Mattis J; Rupprecht CE
Vaccine; 2009 Nov; 27(51):7194-7. PubMed ID: 19925952
[TBL] [Abstract][Full Text] [Related]
26. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus.
Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A
Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514
[TBL] [Abstract][Full Text] [Related]
27. [Simian adenovirus 20 genome. I. DNA mapping using restriction enconucleases BamHI, EcoRi, XbaI, HindIII].
Denisova TS; Gibadulin RA; Sitnikov BS; Senkevich TG; Medvedkina OA
Mol Biol (Mosk); 1980; 14(3):708-20. PubMed ID: 6250025
[TBL] [Abstract][Full Text] [Related]
28. Designing future vaccines.
Brown F
J Hosp Infect; 1991 Jun; 18 Suppl A():164-9. PubMed ID: 1679780
[TBL] [Abstract][Full Text] [Related]
29. High definition viral vaccine strain identity and stability testing using full-genome population data--The next generation of vaccine quality control.
Höper D; Freuling CM; Müller T; Hanke D; von Messling V; Duchow K; Beer M; Mettenleiter TC
Vaccine; 2015 Oct; 33(43):5829-5837. PubMed ID: 26387431
[TBL] [Abstract][Full Text] [Related]
30. A dual dominant selection, dual marker gene amplification model for environmental surveillance of recombinant viral vaccines.
Katz JB
Res Virol; 1990; 141(6):591-6. PubMed ID: 2087597
[TBL] [Abstract][Full Text] [Related]
31. Evidence that adenovirus type 2 can infect human placenta in vitro.
Freund E; Eller M; Kellner K; McGuire PM
Placenta; 1981; 2(3):265-70. PubMed ID: 6269110
[No Abstract] [Full Text] [Related]
32. Engineered XcmI cassette-containing vector for PCR-based phylogenetic analyses.
Aranishi F; Okimoto T
J Genet; 2004 Apr; 83(1):33-4. PubMed ID: 15240906
[No Abstract] [Full Text] [Related]
33. Restriction enzyme maps for equine adenovirus 1 genome.
Sheppard M; Drysdale SM; Studdert MJ
Vet Microbiol; 1992 Jun; 31(4):343-9. PubMed ID: 1496807
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the genome of a vaccine strain of canine adenovirus type 1.
Liu YC; Abouhaidar MG; Sira S; Campbell JB
Virus Genes; 1988 Oct; 2(1):69-81. PubMed ID: 2852417
[TBL] [Abstract][Full Text] [Related]
35. Environmental safety assessment of vaccines derived from biotechnology.
Pastoret PP; Brochier B; Denis M
Rev Sci Tech; 1995 Dec; 14(4):963-77. PubMed ID: 8639965
[TBL] [Abstract][Full Text] [Related]
36. Vaccines, cells, and nucleic acids. Workshop on vaccines prepared in continuous mammalian cell lines and by recombinant systems. London, July 1989. Proceedings.
J Med Virol; 1990 May; 31(1):1-66. PubMed ID: 2376724
[No Abstract] [Full Text] [Related]
37. Exciting potential of DNA vaccines explored.
Marwick C
JAMA; 1995 May; 273(18):1403-4. PubMed ID: 7723142
[No Abstract] [Full Text] [Related]
38. Approaches for genetic purity testing of live recombinant viral vaccines using a human adenovirus:rabies model.
Lutze-Wallace C; Sapp T; Nadin-Davis SA; Wandeler A
Can J Vet Res; 1992 Oct; 56(4):360-4. PubMed ID: 1477804
[TBL] [Abstract][Full Text] [Related]
39. In vitro assessments of the genetic stability of a live recombinant human adenovirus vaccine against rabies.
Lutze-Wallace C; Sapp T; Sidhu M; Wandeler A
Can J Vet Res; 1995 Apr; 59(2):157-60. PubMed ID: 7648530
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
